For surgeons resecting solid tumors or navigating intricate anatomical structures, precise visual clarity isn’t just an advantage. It is the bridge to better patient outcomes.
Conventional optical imaging agents, however, frequently deliver non-specific binding, slow blood clearance, and background signals that obscure real-time surgical views. To truly empower surgeons to see every margin and protect vital structures, Curadel turned to a phenomenon of molecular chemistry: zwitterionicity.
A zwitterion molecule carries an equal number of positive and negative electrical charges, rendering it electrically neutral. In the body, this charge balance creates an ultra-hydrophilic barrier that resists non-specific binding to off-target biological surfaces and proteins. This non-binding is critical when integrated into near-infrared (NIR) fluorescent imaging agents, such as Curadel’s novel fluorophores. Instead of lingering in healthy tissues and creating background “noise”, these molecules remain stable and highly soluble, enabling crisp contrast precisely where it matters for effective surgical procedures and then clearing rapidly from the body.
By applying zwitterionic principles to surgical imaging, Curadel is redefining real-time optical guidance in the operating room. Whether highlighting tumor margins or vulnerable structures like ureters during complex pelvic resections, these targeted fluorophores deliver high signal-to-noise ratios with unprecedented speed and clarity.
Curadel equips surgeons with clear visual intelligence to preserve healthy tissue, achieve complete resections, and deliver optimal patient outcomes. We believe, “Seeing is Curing.”
